AMBER FLEMING: Open Payments
NPI 1740967553 · GALESBURG, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 9 payments from 5 companies in 2025. Trend: 2023 $122 · 2024 $503 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $207 |
| Verona Pharma, Inc. | 3 | $152 |
| Grifols USA, LLC | 1 | $121 |
| AstraZeneca Pharmaceuticals LP | 1 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $107 |
Products named: NUCALA, Ohtuvayre, Prolastin-C Liquid, FASENRA, OFEV, TRELEGY ELLIPTA.
Industry payments across IL — which companies pay providers there.
